Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valens Company Inc (The) Ordinary Shares VLNCF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada... see more

Recent & Breaking News (OTCQX:VLNCF)

In an industry laden with losses, Aphria & Valens resist trend by posting profits

Stockhouse Editorial April 16, 2020

The Valens Company Commences Trading on the Toronto Stock Exchange

Canada NewsWire April 16, 2020

Live Investor Conference & Webinar: Cannabis & Psychedelics Industry Companies Present April 20th

Canada NewsWire April 15, 2020

The Valens Company Reports Record Revenue And Profitable First Quarter Of Fiscal 2020

Canada NewsWire April 14, 2020

The Valens Company Begins Production of Hand Sanitizer to Help Combat COVID-19 Pandemic

Canada NewsWire April 8, 2020

The Valens Company to Hold Conference Call to Discuss Financial Results for the First Quarter of Fiscal 2020

PR Newswire April 7, 2020

The Valens Company Receives Conditional Approval to Graduate to the TSX

Canada NewsWire March 31, 2020

Canopy Growth ships first cannabis-infused beverage across Canada

Stockhouse Editorial March 16, 2020

The Valens Company Launches White Label Cannabis-Infused Beverages In Canada

PR Newswire March 5, 2020

The Valens Company Reports Record Financial Performance in the Fourth Quarter and Fiscal Year Ended November 30, 2019 with Q4 Adjusted EBITDA(1) of $17.7 Million

Canada NewsWire February 24, 2020

The Valens Company to Hold Conference Call to Discuss Financial Results for the Fourth Quarter and Fiscal Year 2019

Canada NewsWire February 20, 2020

The Valens Company to Export First International White Label Products to Australia

Canada NewsWire February 18, 2020

The Valens Company Secures DTC Eligibility

Canada NewsWire January 16, 2020

Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

Canada NewsWire January 13, 2020

Live Investor Conference & Webinar: Cannabis Industry Companies Present January 9th

PR Newswire January 8, 2020

Live Investor Conference & Webinar: Cannabis Industry Companies Present January 9th

Canada NewsWire January 6, 2020

The Valens Company Announces TSXV Approval of Normal Course Issuer Bid

Canada NewsWire December 18, 2019

Valens GroWorks Corp. rebrands to 'The Valens Company' demonstrating leadership in both extraction and commercializing innovative, cannabinoid-based products

Canada NewsWire December 17, 2019

Valens Announces Revenue Guidance for Fourth Quarter 2019 and Intention to Commence a Normal Course Issuer Bid

Canada NewsWire December 16, 2019

Valens expands Exclusive Licence Agreement to Bring Leading Cannabis-Infusion Technology to New International Markets

Canada NewsWire December 11, 2019